Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A successful treatment for hepatocellular carcinoma with Osler-Rendu-Weber disease using radiofrequency ablation under laparoscopy.
Takaoka Y, Morimoto N, Miura K, Nomoto H, Murayama K, Hirosawa T, Watanabe S, Fujieda T, Ttsukui M, Kawata H, Niki T, Isoda N, Iijima M, Yamamoto H. Takaoka Y, et al. Among authors: murayama k. Clin J Gastroenterol. 2018 Dec;11(6):501-506. doi: 10.1007/s12328-018-0877-x. Epub 2018 Jun 16. Clin J Gastroenterol. 2018. PMID: 29909559
The successful treatment of hepatocellular carcinoma arising from congenital hepatic fibrosis using radiofrequency ablation under laparoscopy.
Hirosawa T, Morimoto N, Miura K, Ono K, Watanabe S, Fujieda T, Murayama K, Takaoka Y, Nomoto H, Tsukui M, Isoda N, Niki T, Tokushige K, Yamamoto H. Hirosawa T, et al. Among authors: murayama k. Clin J Gastroenterol. 2019 Jun;12(3):223-230. doi: 10.1007/s12328-018-00932-0. Epub 2019 Jan 7. Clin J Gastroenterol. 2019. PMID: 30617852
Usefulness of Gd-EOB-DTPA-enhanced MRI for evaluating the potential for early development of hepatocellular carcinoma after HCV eradication by direct-acting antiviral treatment.
Morimoto N, Miura K, Watanabe S, Tsukui M, Takaoka Y, Nomoto H, Murayama K, Hirosawa T, Goka R, Kunitomo N, Nakamura H, Sugimoto H, Isoda N, Yamamoto H. Morimoto N, et al. Among authors: murayama k. J Rural Med. 2019 May;14(1):78-86. doi: 10.2185/jrm.2993. Epub 2019 May 30. J Rural Med. 2019. PMID: 31191770 Free PMC article.
No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity.
Hirosawa T, Morimoto N, Miura K, Tahara T, Murohisa T, Okamura Y, Sato T, Numao N, Imai M, Tano S, Murayama K, Kurata H, Ozawa I, Fukaya Y, Yoshizumi H, Watanabe S, Tsukui M, Takaoka Y, Nomoto H, Isoda N, Yamamoto H. Hirosawa T, et al. Among authors: murayama k. Intern Med. 2019 Feb 15;58(4):477-485. doi: 10.2169/internalmedicine.1194-18. Epub 2018 Oct 17. Intern Med. 2019. PMID: 30333396 Free PMC article.
Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infection.
Watanabe S, Morimoto N, Miura K, Murohisa T, Tahara T, Sato T, Tano S, Fukaya Y, Kurata H, Okamura Y, Numao N, Uehara K, Murayama K, Nakazawa K, Sugaya H, Yoshizumi H, Iijima M, Tsukui M, Hirosawa T, Takaoka Y, Nomoto H, Maeda H, Goka R, Isoda N, Yamamoto H. Watanabe S, et al. Among authors: murayama k. J Rural Med. 2020 Oct;15(4):139-145. doi: 10.2185/jrm.2020-004. Epub 2020 Oct 1. J Rural Med. 2020. PMID: 33033533 Free PMC article.
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.
Higashi-Kuwata N, Bulut H, Hayashi H, Tsuji K, Ogata-Aoki H, Kiso M, Takamune N, Kishimoto N, Hattori SI, Ishii T, Kobayakawa T, Nakano K, Shimizu Y, Das D, Saruwatari J, Hasegawa K, Murayama K, Sukenaga Y, Takamatsu Y, Yoshimura K, Aoki M, Furusawa Y, Okamura T, Yamayoshi S, Kawaoka Y, Misumi S, Tamamura H, Mitsuya H. Higashi-Kuwata N, et al. Among authors: murayama k. PNAS Nexus. 2025 Jan 7;4(1):pgae578. doi: 10.1093/pnasnexus/pgae578. eCollection 2025 Jan. PNAS Nexus. 2025. PMID: 39831159 Free PMC article.
Successful Diagnosis of Sengers Syndrome Using a Comprehensive Genomic Analysis.
Nakamura K, Yatsuka Y, Naito S, Hasegawa A, Kasukawa T, Kondo A, Kishita Y, Sugiyama Y, Onuki T, Ebihara T, Tsuruoka T, Fushimi T, Ohtake A, Murayama K, Imai-Okazaki A, Okazaki Y. Nakamura K, et al. Among authors: murayama k. Mol Genet Genomic Med. 2025 Jan;13(1):e70048. doi: 10.1002/mgg3.70048. Mol Genet Genomic Med. 2025. PMID: 39817524 Free PMC article.
1,140 results